CONTINUE TO SITE

OR WAIT null SECS

Advertisement

Carl Zeiss Case Studies High-Frequency Deep Sclerotomy A MIGS Procedure for Mild-to-Moderate Glaucoma iCare COMPASS Automated Perimeter

Carl Zeiss Case Studies High-Frequency Deep Sclerotomy A MIGS Procedure for Mild-to-Moderate Glaucoma iCare COMPASS Automated Perimeter

View More Cataract & Refractive Cornea Gene Therapy Glaucoma Inflammation & Infection Paediatrics Retina

Cataract & Refractive Cornea Gene Therapy Glaucoma Inflammation & Infection Paediatrics Retina

Medical World News

Eyeviews Medical World News Podcasts Rapid Readouts Viewpoints

Digital Edition

Supplements And Featured Publications

Digital Edition Supplements And Featured Publications

Conference Coverage

Conference Listing

Zeiss Case Studies

Roche Video Series

Sponsored Zeiss Case Studies Roche Video Series

Print Subscription

eNewsletter Print Subscription

Advertise
Editorial Info
Contact Us
Terms and Conditions
Privacy
Do Not Sell My Personal Information

© 2023 MJH Life Sciences and Opthalmology Times Europe. All rights reserved.

.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Advertisement

Spotlight

Carl Zeiss Case Studies
High-Frequency Deep Sclerotomy A MIGS Procedure for Mild-to-Moderate Glaucoma
iCare COMPASS Automated Perimeter

ClinicalSee All >

Cataract & Refractive
Cornea
Gene Therapy
Glaucoma
Inflammation & Infection
Paediatrics
Retina

Advertise
Editorial Info
Contact Us
Terms and Conditions
Privacy
Do Not Sell My Personal Information

© 2023 MJH Life Sciences^™ and Opthalmology Times Europe. All rights reserved.

New therapy enters trials

Published on: July 8, 2008

INO-8875, an Adenosine 1 agonist in Phase I testing for the treatment of glaucoma, has begun patient enrolment.

Related Content:

ArticlesGlaucoma

Glaucoma 360: Glaucoma Progression from Hypotension

Glaucoma 360: Glaucoma Progression from Hypotension

Glaucoma 360: Eyedrop targets and reduces episcleral venous pressure in glaucoma

Glaucoma 360: Eyedrop targets and reduces episcleral venous pressure in glaucoma

Atropine instillation after glaucoma surgery may impair vision, prolong rehabilitation time

Atropine instillation after glaucoma surgery may impair vision, prolong rehabilitation time

Advertisement

Advertisement